CDD (CEO BARRY BUNIN) participated in ‘BIO KOREA 5’ held at COEX in Seoul for 10 days from Wednesday, May 12th to Friday, May 3th.
Founded in 2004, CDD (Collaborative Drug Discovery) provides intuitive compound and biological research data management programs to academia, biotech, and drug discovery industries. CDD’s data management cloud platform, CDD Vault®, can integrate and manage biological and chemical information and provides an intuitive web interface convenient for collaboration.
We also participated in this exhibition to introduce CDD Vault® to the Korean market. CDD Vault® registers chemical and biological substances, manages substance usage, metal purity analysis data, experimental data, and calculates structure-activity correlation (SAR) to help manage various candidate substances on one platform. You can also analyze and share research results using Electronic Research Note (ELN).
CDD Vault® was cited as an advantage in that it systematically analyzes, stores, and manages chemical structure and biological research data and allows collaboration with internal and external collaborators through a web interface. It consists of activity and registration, visualization, inventory, and electronic research notes, and its strengths include an intuitive interface, powerful functions, security, easy sharing, and industry-leading customer support.
A CDD official said, “Our goal is to create an unparalleled environment for collaborative research and development. CDD Vault®, developed with this in mind, presents a modern approach to drug development and research informatics.” revealed.
He continued, “As a database that safely manages biological and chemical data inside and outside the facility, CDD Vault® is used by thousands of users and hundreds of organizations around the world, realizing efficiency. “The number of companies in Korea that have successfully adopted CDD Vault® exceeds 20,” he said. “We are not satisfied with this and are regularly updating additional new features of CDC Vault®.”
Meanwhile, ‘BIO KOREA 18’, which celebrated its 2023th anniversary this year, was hosted by the Korea Health Industry Development Institute and Chungcheongbuk-do. BIO KOREA, which has been striving to improve the global status and sustainable growth of the Korean health industry since 2006, is solidifying its position as Korea’s representative biohealth international convention with the participation of world-class scholars and business experts every year. BIO KOREA 2023, in collaboration with companies related to the health industry such as domestic and foreign bio, pharmaceuticals, medical devices, cosmetics, and food, as well as interested companies and institutions such as consulting, academia, and related organizations, will be held through various programs such as conferences, business partnering, exhibitions, and investment fairs. It went ahead.